Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Vyant Bio, Inc. (CGIX) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/31/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
05/15/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
05/10/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/04/2023 25 Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities:
04/24/2023 8-K Quarterly results
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/28/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/28/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/28/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/28/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/28/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/28/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/24/2023 8-K Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive ...
03/24/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/24/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/24/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/24/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/24/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/24/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/24/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/24/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/24/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/24/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/24/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/24/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/22/2023 8-K Quarterly results
03/15/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Vyant Bio, Inc. and Sabine Brandt as trustee for the Brandt Family Trust Share Purchase Agreement Page 1 of 16 1 Definitions and interpretation 4 1.1 Definitions 4 1.2 Interpretation 6 1.3 Business Day 7 1.4 Payments 7 2 Sale and purchase 7 2.1 Sale Shares and Retained Liabilities 7 2.2 Purchase Price 7 2.3 Associated Rights 7 2.4 Title and risk 7 2.5 German Employees 7 2.6 OG / Asalyxa 7 3 Sale mechanics 8 3.1 Seller’ s obligations on the Effective Date 8 3.2 Buyer’ s obligations on the Effective Date 8 4 Final Cash Amount 9 5 Warranties 9 5.1 Mutual Warranties 9 5.2 Seller Warranties 9 5.3 Buyer Warranties 9 5.4 Warranties Independent 10 5.5 Reliance 10 6 Other obligations following sale 10 6.1 Access to records by Seller 10 6.2 Returns 10 6.3 Non-disparagement 11 6.4 Notices to ASIC 11 ..."
03/13/2023 8-K Other Events  Interactive Data
02/27/2023 4 Hansen Paul R. (Director) has filed a Form 4 on Vyant Bio, Inc.
Txns: Acquired (by will) 6,783 shares @ $0
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/03/2023 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "Investor Contact:"
01/19/2023 4 Hansen Paul R. (Director) has filed a Form 4 on Vyant Bio, Inc.
Txns: Granted 4,032 shares @ $0
01/19/2023 4 Harris Geoffrey E. (Director) has filed a Form 4 on Vyant Bio, Inc.
Txns: Granted 5,712 shares @ $0
01/19/2023 4 FLETCHER R JOHN (Director) has filed a Form 4 on Vyant Bio, Inc.
Txns: Granted 4,368 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy